Development of an annual test to inform women about their future fertility

The contract aims to develop an annual diagnostic test that empowers women with actionable insights into their future fertility by identifying novel biomarkers capable of estimating the timeline toward infertility. This initiative seeks to enable proactive fertility planning before medical interventions like IVF become necessary, supporting broader efforts to enhance natural reproductive health. The resulting tool must be cost-effective, safe for repeated yearly use, and deliver clear, accessible results to both patients and healthcare providers to inform timely childbearing decisions. Funded under ARPA-H solicitation number 01 by the Department of Health and Human Services, this project is designated as a total small business set-aside under the SBIR/STTR mandate, restricted to businesses with fewer than 500 employees. It falls under NAICS code 325413 and is open for proposals until September 30, 2027. The focus is on translating scientific discovery into a scalable, user-friendly monitoring technology that can be integrated into routine women’s health care, ultimately guiding the development of future tools for fertility tracking and health improvement.